Evidence map›Paper›PMID 33327504›Full record

ReviewMolecules (Basel, Switzerland)2020

Tetrabutylammonium Bromide (TBAB) Catalyzed Synthesis of Bioactive Heterocycles.

Bimal Krishna Banik, Bubun Banerjee, Gurpreet Kaur, Shivam Saroch, Rajat Kumar

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bimal Krishna BanikDepartment of Mathematics and Natural Sciences, College of Sciences and Human Studies, Deanship of Research Development, Prince Mohammad Bin Fahd University, Al Khobar 31952, Saudi Arabia.
Bubun BanerjeeDepartment of Chemistry, Indus International University, V.P.O. Bathu, Distt. Una, Himachal Pradesh 174301, India.ORCID 0000-0001-7119-9377
Gurpreet KaurDepartment of Chemistry, Indus International University, V.P.O. Bathu, Distt. Una, Himachal Pradesh 174301, India.
Shivam SarochDepartment of Chemistry, Indus International University, V.P.O. Bathu, Distt. Una, Himachal Pradesh 174301, India.
Rajat KumarDepartment of Chemistry, Indus International University, V.P.O. Bathu, Distt. Una, Himachal Pradesh 174301, India.
Prince Mohammad bin Fahd University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last two decades, tetrabutylammonium bromide (TBAB) has gained significant attention as an efficient metal-free homogeneous phase-transfer catalyst. A catalytic amount of TBAB is sufficient to catalyze various alkylation, oxidation, reduction, and esterification processes. It is also employed as an efficient co-catalyst for numerous coupling reactions. It has also acted as an efficient zwitterionic solvent in many organic transformations under molten conditions. In this review, we have summarized the recent developments on TBAB-catalyzed protocols for the efficient synthesis of various biologically promising heterocyclic scaffolds.

Indexed as

Chemistry Techniques, SyntheticAlkylationBiological ProductsCatalysisEsterificationHeterocyclic CompoundsHumansOxidation-ReductionQuaternary Ammonium CompoundsSolventsBiological ProductsHeterocyclic CompoundsQuaternary Ammonium CompoundsSolventstetrabutylammoniumbioactive heterocyclesmetal-free synthesisphase-transfer catalystTBABtetrabutylammonium bromide

Identifiers

PMID33327504
PMCPMC7764977
OpenAlexW3111764970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.